Login / Signup

Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center.

Diana Paola Arteaga CeballosZaid Saeed-KamilIan KingTracy L StockleyDiane LiuThiago P MunizSamuel D SaibilDavid HoggAnna SpreaficoMarcus O Butler
Published in: JCO oncology practice (2022)
test results in TAT. One factor affecting this timeline is the transfer time, which can be streamlined by pathology reflex testing. Delays in TAT affect the timing and type of therapeutic intervention, especially in patients with stage IV disease.
Keyphrases
  • tertiary care
  • papillary thyroid
  • randomized controlled trial
  • squamous cell
  • stem cells
  • squamous cell carcinoma
  • bone marrow
  • replacement therapy
  • smoking cessation